Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, 11 1997, 736-741, Vol 4, No. 6
AH Patki, DL Georges and MM Lederman
We examined the relationships among CD4+-T-cell counts, spontaneous
apoptosis, and Fas expression among peripheral blood mononuclear cells
obtained from human immunodeficiency virus type 1 (HIV-1)-infected
patients. After 2 days of incubation, propidium iodide DNA staining and
flow cytometry revealed that peripheral blood mononuclear cells from
subjects with the lowest CD4+-cell numbers (0 to 99/microl; n = 20) showed
the highest frequency of apoptosis: 22.4% +/- 2.7% (mean +/- standard
error) versus 13.8% +/- 1.2% and 12.7% +/- 1.4% among peripheral blood
mononuclear cells obtained from patients with 100 to 499 CD4+ cells/microl
(n = 19) and >500 CD4+ cells/microl (n = 17), respectively. Each of
these means differed significantly from the mean frequency of apoptosis
(6.3% +/- 0.7%) of peripheral blood mononuclear cells obtained from
HIV-1-seronegative controls (P < 0.001, Student's t test). After
incubation, the percentage of peripheral blood mononuclear cells expressing
Fas antigen was increased for the HIV-1-infected subjects, and this was
most evident for patients with more advanced disease. Among patients with
fewer than 100 CD4+ cells/microl, 64.4% +/- 5.4% of peripheral blood
mononuclear cells were Fas+, as opposed to 25.8% +/- 3.0% and 14.5% +/-
1.7% Fas+ cells among patients with more than 100 CD4+ cells/microl and
healthy controls, respectively (P < 0.05 for each group comparison).
Interestingly, in all populations, most apoptotic cells did not express
Fas. Thus, apoptosis and Fas expression are increased in incubated
peripheral blood mononuclear cells obtained from HIV-1-infected patients
and these phenomena are enhanced as disease progresses.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
CD4+-T-cell counts, spontaneous apoptosis, and Fas expression in peripheral blood mononuclear cells obtained from human immunodeficiency virus type 1-infected subjects
ACTG Immunology Advanced Technology Laboratory and the Center for AIDS Research, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, USA.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»